Stopping Wegovy After Weight Loss — What the Evidence Really Shows

The myth: weight loss 'sticks' once you've reached your goal and stop

The most common misconception about stopping Wegovy is that the weight lost during treatment is locked in, that you've reset your body and can step away from the medicine once the scale reaches your target. The clinical picture is more complicated than that.

The STEP 1 trial extension, published in the New England Journal of Medicine, followed participants who had lost around 15% of their body weight on semaglutide 2.4mg. One year after stopping, they had regained roughly two-thirds of that weight on average. Waist circumference, blood pressure and blood sugar levels also drifted back toward pre-treatment values over the same period. This is not a failure of the medicine, it is exactly what the physiology predicts. Obesity is a chronic condition with a biological basis. Semaglutide manages it while you take it; it does not permanently alter the underlying signals that drive hunger and fat storage.

That said, "most people regain most of the weight" is a population average. Some individuals retain more of their loss than others, particularly those who have made durable changes to their eating patterns and activity levels during treatment. The medicine creates a window, what happens inside that window shapes what comes after.

What your body is doing when you stop

Semaglutide mimics GLP-1, a gut hormone that slows gastric emptying, reduces appetite and acts on the brain's satiety centres. When you inject weekly, that effect is continuous. When you stop, it fades within days as the medicine clears your system (semaglutide has a half-life of roughly one week, so it takes several weeks to fully leave the body).

As it clears, most people notice hunger returning, sometimes gradually, sometimes quite sharply. Food feels less filling. Portions that felt adequate during treatment may feel insufficient. The NHS semaglutide information confirms that the medicine works by acting on receptors involved in appetite regulation, and those receptors simply revert to their previous state once the medicine is gone.

This is why a plan matters. Stopping on a Tuesday because the last pen ran out is very different from stopping after a structured conversation with your prescriber about what support, dietary structure and monitoring will replace the pharmacological effect. If you want to understand what stopping Wegovy actually involves, including what to discuss with your prescriber and how to prepare, it helps to go in informed. People who have used the treatment period to build consistent habits (regular meals, adequate protein, strength-based activity) tend to fare better, though no lifestyle change fully replicates what the medicine does biologically.

If you are curious about the fuller picture of what to expect after stopping Wegovy, including the timeline and practical steps, there is a dedicated resource that covers it in detail.

Does stopping gradually make a difference?

Many people assume that tapering down through lower doses before stopping entirely will reduce weight regain. The evidence for this is limited. Semaglutide's titration schedule is designed to improve tolerability at the start of treatment, there is no equivalent clinical rationale for a reverse taper on the way out. The body's response to the absence of the medicine is governed by clearance time, not dose steps, and the clearance is relatively predictable regardless of how you stop.

That does not mean stopping abruptly is always straightforward. If you have been on the 2.4mg maintenance dose for many months and stop suddenly, the shift in appetite can feel significant. A prescriber may still recommend a gradual reduction on individual grounds, for example, if there are concerns about GI side effects reversing, or if there are other clinical factors at play. The point is that tapering is not a reliable way to hold on to weight lost, even if it can make the transition more comfortable for some people.

The question of whether you are likely to gain weight back after stopping Wegovy is one our prescribers hear regularly; the honest answer involves more than just how you stop.

Planning a stop that makes clinical sense

If stopping is the right decision for you (whether because you have reached a stable weight, because side effects have been persistent, or because of cost) the planning conversation with your prescriber should cover several things before the last pen is used.

First, what is the realistic expectation for weight over the next six to twelve months? Going in with an honest forecast is more useful than hoping to be an outlier. Second, what eating and activity habits are already in place, and which ones need reinforcing? Third, is there a plan to monitor weight at regular intervals rather than waiting until regain is significant before acting?

For people considering the cost angle, it is worth understanding how Wegovy is priced in the UK, some find that a planned continuation at a lower dose is more affordable than restarting from scratch after regain. That calculation is worth having with a prescriber rather than making it by default.

There is also the question of whether stopping Wegovy means stopping treatment altogether, or whether an alternative might suit the next phase better. Understanding what weight loss looks like after Wegovy, and how to approach that phase with realistic expectations, is a conversation worth having before you stop rather than after. The weight management options available through a regulated UK prescriber are broader than a single medicine. Whatever the route forward, it should be a decision made with clinical input, not around it.

If you would like to talk through stopping, pausing or what comes next with a clinician who has reviewed your full history, speak to our prescribers, our team is available seven days a week.